Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

India’s weight loss category is undergoing a dynamic transformation triggered by scientific improvements, pharma innovation, and growing consumer demand ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

In one study, once-daily danuglipron resulted in one patient who experienced drug-related elevated liver enzymes.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

The growing prevalence of diabetes, primarily due to obesity, aging populations, and sedentary lifestyles, is a key factor ...

The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users ...